Jin-Tai Yu Selected Research

Jin-Tai Yu Research Topics

Disease

210	Alzheimer Disease (Alzheimer's Disease) 04/2024 - 02/2009
57	Cognitive Dysfunction 03/2024 - 01/2014
56	Dementia (Dementias) 04/2024 - 01/2014
30	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2024 - 12/2012
21	Atrophy 03/2024 - 04/2012
16	Disease Progression 03/2024 - 04/2012
14	Stroke (Strokes) 04/2024 - 07/2014
14	Tauopathies 11/2023 - 10/2014
12	Inflammation (Inflammations) 04/2024 - 02/2011
11	Hypertension (High Blood Pressure) 01/2024 - 10/2013
11	Parkinson Disease (Parkinson's Disease) 03/2023 - 05/2014
9	Neuroinflammatory Diseases 12/2021 - 04/2012
9	Epilepsy (Aura) 05/2015 - 05/2010
8	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2023 - 02/2014
8	Frontotemporal Dementia (Semantic Dementia) 01/2023 - 02/2014
8	Ischemic Stroke 12/2020 - 02/2010
6	Genetic Predisposition to Disease (Genetic Predisposition) 01/2024 - 01/2014
6	Pathologic Constriction (Stenosis) 04/2020 - 01/2019
5	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 01/2023 - 05/2013
5	Mitochondrial Diseases (Mitochondrial Disease) 01/2022 - 11/2009
5	Infarction (Infarctions) 12/2020 - 07/2014
5	Seizures (Absence Seizure) 01/2015 - 05/2011
4	Nervous System Diseases (Neurological Disorders) 01/2023 - 10/2014
4	Obesity 01/2023 - 11/2020
4	Amyloid Plaque 11/2017 - 01/2014
4	Neoplasms (Cancer) 05/2015 - 10/2013
3	Anemia 01/2024 - 10/2022
3	Diabetes Mellitus 01/2023 - 01/2019
3	Hearing Loss (Hearing Impairment) 12/2022 - 01/2019
3	Cerebrovascular Disorders (Cerebrovascular Occlusion) 10/2022 - 10/2013
3	Pathologic Processes 01/2022 - 01/2016
3	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 01/2018 - 01/2016
3	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 08/2015 - 07/2014
2	Coronary Disease (Coronary Heart Disease) 04/2024 - 11/2021
2	Venous Thromboembolism 04/2024 - 01/2021
2	Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy) 02/2024 - 12/2022
2	Multiple System Atrophy 03/2023 - 01/2023
2	Spinocerebellar Ataxias (Spinocerebellar Ataxia) 03/2023 - 01/2023
2	Multiple Sclerosis 01/2023 - 01/2023
2	Hemorrhage 01/2023 - 01/2017

Drug/Important Bio-Agent (IBA)

99	Biomarkers (Surrogate Marker)IBA 04/2024 - 01/2013
61	Amyloid (Amyloid Fibrils)IBA 03/2024 - 02/2011
29	Proteins (Proteins, Gene)FDA Link 04/2024 - 08/2013
17	Apolipoproteins E (ApoE)IBA 11/2023 - 04/2012
16	Glucose (Dextrose)FDA LinkGeneric 01/2024 - 07/2012
14	tau Proteins (tau Protein)IBA 12/2022 - 05/2013
13	ApolipoproteinsIBA 01/2021 - 08/2013
12	Amyloid beta-PeptidesIBA 10/2023 - 11/2009
11	MicroRNAs (MicroRNA)IBA 01/2017 - 01/2013
9	Peptides (Polypeptides)IBA 01/2019 - 02/2013
7	ClusterinIBA 01/2016 - 10/2010
6	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 06/2022 - 05/2011
6	CytokinesIBA 01/2016 - 02/2009
5	Cystatin CIBA 04/2024 - 01/2022
5	LipidsIBA 01/2024 - 01/2020
5	LDL Lipoproteins (beta Lipoproteins)IBA 12/2023 - 11/2019
5	CholesterolIBA 04/2023 - 01/2015
5	Uric Acid (Urate)IBA 01/2022 - 04/2020
4	AlbuminsIBA 01/2024 - 01/2022
4	oxidized low density lipoproteinIBA 12/2023 - 01/2022
4	Carrier Proteins (Binding Protein)IBA 10/2022 - 02/2011
4	SynucleinsIBA 05/2022 - 11/2014
4	InflammasomesIBA 01/2015 - 12/2013
3	Antipsychotic Agents (Antipsychotics)IBA 01/2024 - 01/2015
3	Alanine Transaminase (SGPT)IBA 12/2023 - 01/2022
3	Glial Fibrillary Acidic ProteinIBA 03/2023 - 01/2023
3	Vitamin D FDA LinkGeneric 01/2023 - 11/2016
3	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2023 - 11/2016
3	ProteomeIBA 01/2023 - 10/2021
3	Sex Hormone-Binding GlobulinIBA 10/2022 - 01/2020
3	NeurograninIBA 01/2022 - 01/2020
3	C-Reactive ProteinIBA 01/2022 - 01/2019
3	Complement System Proteins (Complement)IBA 01/2022 - 08/2010
3	CalciumIBA 06/2021 - 11/2009
3	Antihypertensive Agents (Antihypertensives)IBA 01/2021 - 01/2020
3	ProgranulinsIBA 10/2020 - 01/2016
3	Apolipoprotein A-I (Apolipoprotein A1)IBA 10/2020 - 01/2019
3	Interleukin-6 (Interleukin 6)IBA 01/2019 - 08/2015
3	Memantine (Namenda)FDA Link 12/2018 - 01/2014
3	Phospholipases (Phospholipase)IBA 01/2016 - 01/2015
3	Phosphotransferases (Kinase)IBA 01/2016 - 10/2014
3	Vesicular Transport Adaptor ProteinsIBA 01/2016 - 04/2014
3	Toll-Like Receptor 2IBA 10/2011 - 02/2011
2	ORALIT (ORS)IBA 04/2024 - 01/2023
2	Blood Proteins (Serum Proteins)IBA 04/2024 - 02/2024
2	Insulin-Like PeptidesIBA 01/2024 - 11/2012
2	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 01/2024 - 10/2023
2	Hemoglobins (Hemoglobin)IBA 01/2024 - 01/2023
2	Air Pollutants (Pollutants, Air)IBA 01/2024 - 01/2023
2	Lipoproteins (Lipoprotein)IBA 01/2024 - 01/2022
2	Linoleic Acid (Linoleate)IBA 01/2024 - 01/2023
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 12/2023 - 10/2023
2	Citric Acid (Citrate)FDA LinkGeneric 12/2023 - 01/2022
2	Valine (L-Valine)FDA Link 12/2023 - 01/2023
2	Fatty Acids (Saturated Fatty Acids)IBA 12/2023 - 01/2022
2	HDL LipoproteinsIBA 12/2023 - 04/2023
2	Risperidone (Risperdal Consta)FDA LinkGeneric 01/2023 - 01/2015
2	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 01/2023 - 01/2023
2	CopperIBA 01/2023 - 01/2015

Therapy/Procedure

28	Therapeutics 01/2024 - 02/2011